RT Book, Section
A1 Sher, David J.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Colson, Yolonda L.
A2 Jaklitsch, Michael T.
A2 Krasna, Mark J.
A2 Mentzer, Steven J.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1105843067
T1 Radiotherapy for Inoperable Non–Small Cell Lung Cancer
T2 Adult Chest Surgery, 2e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-178189-3
LK accesssurgery.mhmedical.com/content.aspx?aid=1105843067
RD 2024/04/24
AB The  multimodality  management  of  inoperable  non–small  cell  lung  cancer  (NSCLC)  –  from  early-stage  disease  to  locally  advanced  presentations  –  has  changed  substantially  over  the  past  20  years.  With  the  exception  of  small,  stage  I  NSCLC,  most  nonmetastatic  patients  are  treated  with  both  local  and  systemic  therapy,  and  there  is  an  increasing  interest  in  the  integration  of  all  three  modalities.  Radiation  oncology  has  experienced  dramatic  technologic  innovations  over  this  time,  which  has  allowed  for  reduced  toxicity  and  consequent  improvements  in  the  therapeutic  ratio,  and  in  the  notable  case  of  stage  I  NSCLC,  significantly  higher  cure  rates.